ACE and chronic kidney disease: In addition to lifestyle changes, standard-of-care pharmacologic treatment options for CKD include angiotensin-converting enzyme inhibitors or angiotensin receptor blockers which aim to delay disease progression and prevent or ameliorate associated complications, yet many patients continue to progress toward advanced CKD.